Le Lézard
Classified in: Health, Science and technology
Subject: PER

Kevin Fitzpatrick Named President and CEO of Enforme Interactive


WASHINGTON, Jan. 14, 2019 /PRNewswire-PRWeb/ -- Today, Enforme Interactive (http://www.enforme.com) announced the appointment of Kevin Fitzpatrick as President and CEO. Fitzpatrick brings with him a long and successful career as a C-level association executive with experience in new business development, medical publishing, international programs, and organizational management.

Fitzpatrick joins Enforme Interactive after most recently serving as a senior advisor to PAIGE.AI, a computational pathology start-up using artificial intelligence and computer vision to enhance early cancer detection.

From 2015 to 2018, he served as the first CEO of CancerLinQtm, a rapid learning system for oncology and a subsidiary of the American Society of Clinical Oncology (ASCO). There he led CancerLinQ through its rapid nationwide adoption and initial strategic transaction.

Prior to CancerLinQ, he served for seven years as the Executive Vice President and Chief Innovation Officer of the American College of Cardiology (ACC), where he jointly led the organization's overall strategic and operational planning.

"Professional organizations play a vital leadership role in the healthcare community. However, they're struggling to stay relevant to a new generation of professionals. Societies are challenged to keep pace with the rapid growth of new knowledge and the technologic expectations of their members. Associations need new tools and new approaches to thrive amidst the accelerating pace of change in healthcare. I'm tremendously proud to be part of the Enforme team as we launch an exciting suite of association services, designed to specifically address these critical issues."

In his leadership role, Fitzpatrick will join Carrie Delente, a founder of Enforme Interactive, who will serve as COO. "In my long career serving professional associations, I've seen, firsthand, the increasing struggle to organize vast amounts of content, break down information silos, and efficiently serve the information needs of members," Delente said. "We're poised to roll out advanced computational services, augmented by artificial intelligence, that will provide hyper-personalized insights to both association executives and their members."

Teaming up with Enforme is a natural step in Fitzpatrick's career. "For over a decade, I've worked with Carrie and Eric Delente and the Enforme team in many different capacities," he said. "Together we've developed successful programs for a wide spectrum of professional organizations."

"We're delighted to have Kevin leading the team," stated Carrie Delente. "He brings with him a tremendous amount of experience in the healthcare space and has a proven track record of success. I'm certain that our present and future clients will greatly benefit from his wisdom and insights."

Enforme Interactive, a well-established custom solutions provider for medical associations, was founded by Eric and Carrie Delente in 1997. Enforme's award-winning team has provided non-profit associations with highly customized cutting-edge design, development, and technical best practices. From websites and apps to online learning, member management, and content delivery, Enforme provides essential services for professional associations across the globe.

 

SOURCE Enforme Interactive


These press releases may also interest you

at 18:30
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice President and Chief Medical Officer. In addition, after four...

at 18:16
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 17:56
The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.  The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12%...

at 17:45
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to...

at 17:31
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIREŽ (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...



News published on and distributed by: